The global zeposia market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Zeposia is a treatment for relapsing forms of multiple sclerosis, which includes clinically isolated syndrome, relapsing syndrome, and a second progressive disease, in adults. The active ingredient in Zeposia, ozanimod, inhibits the activity of sphingosine-1-phosphate receptors in lymphocytes […]
